联环药业
(600513)
| 流通市值：47.47亿 | | | 总市值：47.47亿 |
| 流通股本：2.85亿 | | | 总股本：2.85亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 1,570,814,170.07 | 810,625,785.82 | 2,711,858,051.35 | 2,082,459,109.35 |
| 营业总成本 | 1,548,886,885.84 | 800,833,222.39 | 2,711,961,483.08 | 2,028,444,912.55 |
| 其他经营收益 | | | | |
| 营业利润 | 25,121,463.79 | 10,983,083.37 | -10,398,904.6 | 59,458,501.69 |
| 利润总额 | 22,404,413.43 | 10,600,496.5 | -87,605,668.22 | -1,497,221.37 |
| 净利润 | 14,756,304.71 | 7,362,385.18 | -84,152,794.56 | -27,722,396.42 |
| 每股收益 | | | | |
| 其他综合收益 | 98,348.85 | 634,095.24 | -124,595.73 | -104,216.08 |
| 综合收益总额 | 14,854,653.56 | 7,996,480.42 | -84,277,390.29 | -27,826,612.5 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,014,263,799.41 | 1,980,727,005.81 | 1,986,128,036.84 | 2,071,311,398.65 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,210,872,808.01 | 2,175,772,209.66 | 2,110,688,108.49 | 2,037,884,083.42 |
| 资产总计 | 4,225,136,607.42 | 4,156,499,215.47 | 4,096,816,145.33 | 4,109,195,482.07 |
| 流动负债: | | | | |
| 流动负债合计 | 2,173,728,023.53 | 2,116,220,267.93 | 2,028,633,157.42 | 1,818,122,785.8 |
| 非流动负债: | | | | |
| 非流动负债合计 | 384,911,078 | 352,528,861.92 | 388,429,382.71 | 553,839,851.43 |
| 负债合计 | 2,558,639,101.53 | 2,468,749,129.85 | 2,417,062,540.13 | 2,371,962,637.23 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,262,385,105.79 | 1,278,805,740.09 | 1,271,746,892.76 | 1,335,037,578.7 |
| 股东权益合计 | 1,666,497,505.89 | 1,687,750,085.62 | 1,679,753,605.2 | 1,737,232,844.84 |
| 负债和股东权益合计 | 4,225,136,607.42 | 4,156,499,215.47 | 4,096,816,145.33 | 4,109,195,482.07 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 1,389,886,665.6 | 708,721,708.4 | 2,941,689,418.21 | 2,081,145,862.63 |
| 经营活动现金流出小计 | 1,474,503,277.49 | 787,676,209.78 | 2,956,159,501.82 | 2,254,027,017.88 |
| 经营活动产生的现金流量净额 | -84,616,611.89 | -78,954,501.38 | -14,470,083.61 | -172,881,155.25 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 31,228.52 | - | 5,695,423.5 | 16,468 |
| 投资活动现金流出小计 | 117,116,108.23 | 59,913,763.79 | 491,696,435.37 | 292,776,850.53 |
| 投资活动产生的现金流量净额 | -117,084,879.71 | -59,913,763.79 | -486,001,011.87 | -292,760,382.53 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 818,864,460.47 | 374,109,337.16 | 1,594,762,062.84 | 1,306,418,218.01 |
| 筹资活动现金流出小计 | 673,436,339.55 | 320,043,119.31 | 1,002,293,336.34 | 776,524,106.49 |
| 筹资活动产生的现金流量净额 | 145,428,120.92 | 54,066,217.85 | 592,468,726.5 | 529,894,111.52 |
| 汇率变动对现金及现金等价物的影响 | -341,247.98 | -269,396.66 | -340,194.21 | 160,194.55 |
| 现金及现金等价物净增加额 | -56,614,618.66 | -85,071,443.98 | 91,657,436.81 | 64,412,768.29 |
| 期末现金及现金等价物余额 | 221,736,703.39 | 193,279,878.07 | 278,351,322.05 | 251,106,653.53 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | -56,614,618.66 | - | 91,657,436.81 | - |